Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial

Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial

Fred Hutchinson Cancer Research Center is an amazing place. At the forefront of combating cancer, recently they recently served as a clinical investigational site for a clinical trial for an investigational CAR-T cell treatment targeting multiple myeloma.

The Patient

Knowing she has few options left, Janice Olson applied for the clinical trial at Seattle-based Fred Hutchinson Cancer Research Center. She was full immersed in a battle for her life against multiple myeloma. She learned of the Phase I study at Fred Hutch from her husband who was diligently searching for clinical research.

Fred Hutch Leads Advanced CAR-T Cell Therapy

In this clinical trial, Ms. Olson’s own T-cells were gathered, changed and injected back into her system and in the process turning her own t-cells into cancer killers. Recently King 5 profiled this study conducted at Fred Hutch.  The local news outlet profiled Dr. Damian Green (Fred Hutch) and Ms. Olson’s journey though this clinical trial her own T-cells were collected, altered and injected back into her body—turning her own t-cells into cancer fighters.

Ms. Olson had little to lose and joined the study which is a Phase...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee